Molecular Microbiology of Enterotoxigenic E. coli Pathogen-Host Interactions
产肠毒素大肠杆菌病原体-宿主相互作用的分子微生物学
基本信息
- 批准号:9926220
- 负责人:
- 金额:$ 24.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-14 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdhesionsAdjuvantAmino AcidsAntigensArchitectureBacterial AdhesinsBacterial AdhesionBangladeshiBindingCell surfaceCellsCessation of lifeChemistryChildCholeraChronicClustered Regularly Interspaced Short Palindromic RepeatsComplementDeveloped CountriesDeveloping CountriesDevelopmentDiarrheaDiseaseDisease susceptibilityElementsEngineeringEpithelialEpithelial CellsEpitheliumEscherichia coli InfectionsEventGene ExpressionGenesGenomeGlycocalyxGlycoproteinsGlycoside HydrolasesGoalsGoblet CellsGrowthHuman VolunteersImmune responseIn VitroIndividualInfectionInstitutesIntestinal MucosaIntestinesInvestigationKineticsLaboratoriesLeadLectinMalnutritionMembraneMembrane ProteinsMicrobiologyMicroscopyModelingMolecularMucin-2 Staining MethodMucinsNatureOrganismPathogenesisPatientsPolysaccharidesProteinsProteomicsRisk FactorsSanitationSmall IntestinesStructureSurfaceSystemTestingThermogenesisTimeToxinVaccine AntigenVaccine DesignVaccinesVirulence FactorsWaterWorkblood groupcarcinoembryonic antigen-related cell adhesion moleculesconfocal imagingdesigndiarrheal diseaseenterotoxigenic Escherichia coligastrointestinal epitheliumglobal healthglycosyltransferasegut colonizationhigh riskimprovedintestinal epitheliummutantnovelnovel strategiespathogenpreventreceptorresponsestem cellstherapy developmentuptakevaccine candidatevaccine development
项目摘要
Project Summary/Abstract
This work focuses on enterotoxigenic Escherichia coli (ETEC), globally the most common bacterial cause of
serious diarrheal illness. These illnesses threaten the lives of many children in poor regions of the world where
sanitation and clean water are limited. While some ETEC are clearly associated with development of cholera-
like diarrhea, basic molecular mechanisms underlying severe illness remain undefined. The long-term goal of
these studies is to address basic questions that can inform our understanding of acute illness and more
chronic sequelae that may impact or approach to development of vaccines for these organisms:
“Why are individuals with blood group A more susceptible to severe infections cause by ETEC ?”
“How does ETEC or its toxins alter intestinal surfaces to promote infection?”
“Are ETEC particularly well-equipped to promote these interactions?”
“Are there other antigens that interact with host cells to promote infections?”
Studies to date have shown us that the pathogenesis of ETEC infection is actually quite complicated,
potentially involving many proteins. Novel proteins that are not part of vaccines currently being tested could be
added to improve the coverage and function of these vaccines. Understanding disease susceptibility on a
molecular level can permit us to protect individuals at the highest risk.
Addressing these fundamental questions will fill important gaps in our understanding of ETEC interactions with
the intestine as well as cellular responses that develop following ETEC infections. Collectively these studies
should permit a more rational approach to development of a broadly protective vaccine for these pathogens of
global importance.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
James Michael Fleckenstein其他文献
James Michael Fleckenstein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('James Michael Fleckenstein', 18)}}的其他基金
Molecular Pathogenesis of enterotoxigenic E. coli associated enteropathy
产肠毒素大肠杆菌相关性肠病的分子发病机制
- 批准号:
10656056 - 财政年份:2023
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9884089 - 财政年份:2020
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10438532 - 财政年份:2020
- 资助金额:
$ 24.01万 - 项目类别:
ShEEP Request for ImageXpress Micro Confocal High Content Screening System
ShEEP 请求 ImageXpress Micro 共焦高内涵筛选系统
- 批准号:
10177122 - 财政年份:2020
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10553173 - 财政年份:2020
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9275348 - 财政年份:2012
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8965936 - 财政年份:2012
- 资助金额:
$ 24.01万 - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8245631 - 财政年份:2012
- 资助金额:
$ 24.01万 - 项目类别:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
产肠毒素大肠杆菌疫苗的新抗原鉴定
- 批准号:
8436769 - 财政年份:2010
- 资助金额:
$ 24.01万 - 项目类别:
Novel Antigen Identification for an Enterotoxigenic E. coli Vaccine
产肠毒素大肠杆菌疫苗的新抗原鉴定
- 批准号:
8680121 - 财政年份:2010
- 资助金额:
$ 24.01万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 24.01万 - 项目类别:
Research Grant














{{item.name}}会员




